Portal de Periódicos da CAPES

Liposomes: structure, composition, types, and clinical applications

2022; Elsevier BV; Volume: 8; Issue: 5 Linguagem: Inglês

10.1016/j.heliyon.2022.e09394

2405-8440

Hamdi Nsairat, Dima Khater, Usamah Sayed, Fadwa Odeh, Abeer Al Bawab, Walhan Alshaer,

Advanced Drug Delivery Systems

Liposomes are now considered the most commonly used nanocarriers for various potentially active hydrophobic and hydrophilic molecules due to their high biocompatibility, biodegradability, and low immunogenicity. Liposomes also proved to enhance drug solubility and controlled distribution, as well as their capacity for surface modifications for targeted, prolonged, and sustained release. Based on the composition, liposomes can be considered to have evolved from conventional, long-circulating, targeted, and immune-liposomes to stimuli-responsive and actively targeted liposomes. Many liposomal-based drug delivery systems are currently clinically approved to treat several diseases, such as cancer, fungal and viral infections; more liposomes have reached advanced phases in clinical trials. This review describes liposomes structure, composition, preparation methods, and clinical applications.